349 related articles for article (PubMed ID: 10051738)
1. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
Joshi S; Lee JW; Wong YH
Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
[TBL] [Abstract][Full Text] [Related]
2. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C.
Lee JW; Joshi S; Chan JS; Wong YH
J Neurochem; 1998 May; 70(5):2203-11. PubMed ID: 9572309
[TBL] [Abstract][Full Text] [Related]
3. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
5. Chimeric Galpha(q) mutants harboring the last five carboxy-terminal residues of Galpha(i2) or Galpha(o) are resistant to pertussis toxin-catalyzed ADP-ribosylation.
Joshi SA; Fan KP; Ho VW; Wong YH
FEBS Lett; 1998 Dec; 441(1):67-70. PubMed ID: 9877167
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the cloned kappa and mu opioid receptors.
Tallent M; Dichter MA; Reisine T
Neuroscience; 1998 Aug; 85(3):873-85. PubMed ID: 9639280
[TBL] [Abstract][Full Text] [Related]
7. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
Stiene-Martin A; Zhou R; Hauser KF
Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
[TBL] [Abstract][Full Text] [Related]
8. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
Shapira M; Vogel Z; Sarne Y
Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
[TBL] [Abstract][Full Text] [Related]
9. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
10. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Zhang J; Haddad GG; Xia Y
Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
[TBL] [Abstract][Full Text] [Related]
11. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
[TBL] [Abstract][Full Text] [Related]
12. Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells.
Fukuda K; Kato S; Shoda T; Morikawa H; Mima H; Mori K
Anesth Analg; 1998 Aug; 87(2):450-5. PubMed ID: 9706949
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
14. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
15. Mu and delta opioids but not kappa opioid inhibit voltage-activated Ba2+ currents in neuronal F-11 cell.
Nah SY; Unteutsch A; Bunzow JR; Cook SP; Beacham DW; Grandy DK
Brain Res; 1997 Aug; 766(1-2):66-71. PubMed ID: 9359588
[TBL] [Abstract][Full Text] [Related]
16. Co-expressions of different opioid receptor types differentially modulate their signaling via G(16).
Ho MK; New DC; Wong YH
Neurosignals; 2002; 11(2):115-22. PubMed ID: 12077485
[TBL] [Abstract][Full Text] [Related]
17. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Galphaq subunits can distinguish the long form of the Xenopus Mel1c melatonin receptor from the mammalian mt1 and MT2 melatonin receptors.
Lai FP; Mody SM; Yung LY; Pang CS; Pang SF; Wong YH
J Pineal Res; 2001 Apr; 30(3):171-9. PubMed ID: 11316328
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
20. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
